0001144204-13-031619.txt : 20130524 0001144204-13-031619.hdr.sgml : 20130524 20130524164956 ACCESSION NUMBER: 0001144204-13-031619 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130523 FILED AS OF DATE: 20130524 DATE AS OF CHANGE: 20130524 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DERMA SCIENCES, INC. CENTRAL INDEX KEY: 0000892160 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 232328753 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 214 CARNEGIE CENTER, SUITE 300 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 6095144744 MAIL ADDRESS: STREET 1: 214 CARNEGIE CENTER, SUITE 300 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DERMA SCIENCES INC DATE OF NAME CHANGE: 19940513 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PAUL AMY S CENTRAL INDEX KEY: 0001235355 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13070 FILM NUMBER: 13872709 MAIL ADDRESS: STREET 1: C.R. BARD, INC. STREET 2: 730 CENTRAL AVENUE CITY: MURRAY HILL STATE: NJ ZIP: 07974 4 1 v346171_form4.xml FORM 4 X0306 4 2013-05-23 0 0000892160 DERMA SCIENCES, INC. DSCI 0001235355 PAUL AMY S 2591 BRENTWOOD DRIVE HOLLADAY UT 84121 1 0 0 0 Common Stock 2013-05-23 4 A 0 10000 0 A 10000 D Stock Option (right to buy) 13.76 2013-05-23 4 A 0 15000 0 A 2014-05-23 2023-05-23 Common Stock 15000 15000 D The shares of common stock reported herein represent restricted stock units issued under the issuer's equity incentive plan and will vest as to 25% of the grant on the first, second, third and fourth anniversaries of the grant date so long as the reporting person remains a director of the issuer. The restricted stock units were granted under the issuer's equity incentive plan and without payment of consideration in connection with the reporting person's appointment to the board of directors of the issuer. The options were issued under the issuer's equity incentive plan and will vest as to 25% of the grant on the first, second, third and fourth anniversaries of the grant date so long as the reporting person remains a director of the issuer. The options were granted under the issuer's equity incentive plan and without payment of consideration in connection with the reporting person's appointment to the board of directors of the issuer. /s/ Amy S. Paul 2013-05-23